0001140361-22-047070.txt : 20221227
0001140361-22-047070.hdr.sgml : 20221227
20221227173103
ACCESSION NUMBER: 0001140361-22-047070
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221222
FILED AS OF DATE: 20221227
DATE AS OF CHANGE: 20221227
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Glenn Jeffrey S
CENTRAL INDEX KEY: 0001670382
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36183
FILM NUMBER: 221491148
MAIL ADDRESS:
STREET 1: 350 CAMBRIDGE AVENUE, SUITE 350
CITY: PALO ALTO
STATE: CA
ZIP: 94306
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eiger BioPharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001305253
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 361004130
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2155 PARK BOULEVARD
CITY: PALO ALTO
STATE: CA
ZIP: 94306
BUSINESS PHONE: 650-279-9845
MAIL ADDRESS:
STREET 1: 2155 PARK BOULEVARD
CITY: PALO ALTO
STATE: CA
ZIP: 94306
FORMER COMPANY:
FORMER CONFORMED NAME: Celladon Corp
DATE OF NAME CHANGE: 20041005
4
1
form4.xml
X0306
4
2022-12-22
0001305253
Eiger BioPharmaceuticals, Inc.
EIGR
0001670382
Glenn Jeffrey S
C/O EIGER BIOPHARMACEUTICALS, INC.
2155 PARK BLVD.
PALO ALTO
CA
94306
true
Common Stock
2022-12-22
4
P
0
100000
1.2795
A
182355
D
Common Stock
5000
I
By spouse
Common Stock
460
I
By son
Common Stock
151064
I
By Eiger Group International, Inc.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.18 to $1.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
Shares are held by Eiger Group International, Inc. ("EGI"). The Reporting Person is the Chief Executive Officer of EGI and has sole power to vote and sole power to dispose of shares directly owned by EGI. The Reporting Person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein.
/s/ Sriram Ryali, Attorney-in-Fact
2022-12-27